Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Review Article · Übersichtsarbeit

Free Access

Critical Appraisal of Randomized Clinical Trials: Can We Have Faith in the Conclusions?

Mittlböck M.

Author affiliations

Core Unit for Medical Statistics and Informatics, Section of Clinical Biometrics, Medical University of Vienna, Austria

Corresponding Author

Prof. Dr. Martina Mittlböck, Core Unit for Medical Statistics and Informatics, Section of Clinical Biometrics, Medical University of Vienna, Spitalgasse 23, 1090 Wien, Austria, Tel. +43 1 40400-2276, Fax -6687, martina.mittlboeck@meduniwien.ac.at

Related Articles for ""

Breast Care 2008;3:341–346

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Randomized clinical trials (RCTs) are the most appropriate research design for studying the effectiveness of a specific intervention. Its results are considered as the highest ‘level of evidence’. Published reports on RCTs have already succeeded in a peer review process, but still there can be undetected major deficiencies of the study that may question the reported outcome. It is still up to the readers to assess the quality of publications and to question if the published results apply to their patients. The major points of such a critical appraisal process are reviewed and discussed with a focus on breast cancer studies.

© 2008 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Review Article · Übersichtsarbeit

Published online: October 16, 2008
Issue release date: November 2008

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 1

ISSN: 1661-3791 (Print)
eISSN: 1661-3805 (Online)

For additional information: https://www.karger.com/BRC

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.